1. France Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Emeis

Emeis

9.73
EUR
-0.19
(-1.96%)
2.25BMarket Cap
May 07Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1,934.22
2,242.28
2,555.85
3,012.18
3,254.6
3,381.82
3,696.93
3,879.19
4,251.04
4,627
40.04
35.81
36.59
- -
Basic EPS, GAAP
137.03
138.98
135.33
311.19
93.12
217.95
231.28
158.28
64.46
-3,980.68
10.44
-2.62
-1.85
- -
Free Cash Flow per Basic Share
297.46
333.88
335.5
367.57
412.66
410.51
797.12
769.16
745.42
405.01
2.82
3
4.22
- -
Dividend per Share
38.25
44.69
47.51
57.51
62.78
70.26
76.64
- -
57.52
- -
- -
- -
- -
- -
Book Value per Share
1,626.25
1,722.22
1,917.67
2,239.11
2,687.68
2,937.86
2,981.06
3,455.65
2,297.51
-1,483.97
14.43
10.69
8.73
8.42
Tangible Book Value per Share
-490.2
-831.1
-830.04
-803.65
-376
-420.06
-745.76
-870.61
-2,394.2
-4,404.16
-7.74
-7.7
-9.64
-10.17
Basic Weighted Avg Shares
1
1
1
1
1
1
1
1
1
1
130
157
161
161
Sales/Revenue/Turnover
1,608
1,949
2,392
2,841
3,138
3,420
3,740
3,922
4,299
4,681
5,198
5,636
5,895
- -
Operating Margin (%)
13.92
14.09
12.46
11.69
12
12.44
13.44
10.87
8.48
-14.19
-2.32
0.03
2.94
- -
Depreciation Expense
71
79
97
126
153
176
446
504
645
350
820
458
346
- -
Net Income, GAAP
114
121
127
294
90
220
234
160
65
-4,027
1,355
-412
-298
- -
Effective Tax Rate (%)
35.3
35.61
32.76
1.7
38.42
30.8
30.26
25
35.49
- -
3.18
- -
- -
- -
Profit Margin (%)
7.08
6.2
5.29
10.33
2.86
6.44
6.26
4.08
1.52
-86.03
26.07
-7.31
-5.06
- -
Working Capital
-340
-235
-79
-137
66
-99
-81
-223
-738
-7,750
-751
-743
-996
-533
LT Debt
1,920
2,479
3,219
3,801
4,622
5,104
8,121
9,207
9,975
4,802
7,856
8,068
7,835
7,299
Total Equity
1,413
1,498
1,810
2,113
2,715
2,971
3,011
3,490
2,335
-1,502
1,888
1,722
1,409
2,108
Return on Invested Capital (%)
3.97
4.18
4.04
5.64
3.33
3.45
3.49
2.61
1.57
- -
-7.61
- -
- -
- -
Return on Capital (%)
4.27
4.17
3.58
6.44
2.19
3.51
3.48
2.52
1.4
- -
16.68
- -
- -
- -
Return on Common Equity (%)
8.67
8.3
7.66
14.97
3.72
7.75
7.82
4.92
2.24
- -
- -
-22.82
-19.05
- -

Capital Structure

EUR

•

in mil. unless spec.
Jun'24
Dec'24
Jun'26
ST Debt
1,189
882
720
LT Borrowings
3,952
4,238
4,113
LT Finance Leases
3,808
3,830
3,186
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
159
161
160
Market Capitalization
2,107
941
2,255

Working Capital

EUR

•

in mil. unless spec.
Jun'24
Dec'24
Jun'26
Total Current Assets
2,418
1,880
2,522
Cash, Cash Equivalents & STI
653
519
590
Accounts Receivable, Net
848
524
769
Inventories
16
16
14
Total Current Liabilities
3,118
2,623
3,054
Payables & Accruals
- -
- -
- -
ST Debt
1,189
882
720
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-37.82%
-90.03%
-18.19%
Free Cash Flow
13.39%
2.74%
44.12%
Net Income, GAAP
-644.64%
-1,325.76%
-27.58%
Sales/Revenue/Turnover
9.5%
8.51%
4.61%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
5,636
2025
- -
- -
5,895
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-2.62
2025
- -
- -
-1.85
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Laurent Guillot
Full Time Employees
84,586
Sector
Health services
Industry
Medical/Nursing services
Address
12, rue Jean-JaurEs Puteaux IDF France 92813
IPO Date
Apr 16, 2002
Website
emeis-group.com
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Emeis Société anonyme (EMEIS.PA), formerly Orpea SA, operates as a leading European provider of personalized healthcare and support services for vulnerable populations, encompassing psychiatric clinics, post-acute and rehabilitation clinics (SMR), nursing homes, senior assisted-living facilities, and home care services; it manages over 1,000 facilities with nearly 83,500 employees across more than 20 countries, primarily in Europe including France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, and others such as Brazil, Russia, China, Uruguay, Colombia, Mexico, Chile, Latvia, Slovenia, and Croatia. The company delivers specialized care in mental health hospitals offering tailored therapies for psychological stability; medical and rehabilitation clinics aiding post-surgery, chronic illness, or accident recovery to restore mobility; nursing homes providing personalized attention for age-related frailties; senior residences enabling independent living with community support; and home care encompassing housekeeping like cleaning, meals, ironing, gardening, daily assistance with hygiene, supervision, and mobility support. Founded in 1989 and headquartered in Puteaux, France, Emeis targets patients, residents, and beneficiaries facing physical, cognitive, or mental vulnerabilities, serving nearly 280,000 individuals annually with a focus on seamless care pathways. In recent developments, Emeis announced on September 23, 2025, a strategic partnership with Farallon Capital as lead investor and TwentyTwo Real Estate to create a dedicated healthcare real estate vehicle for 68 assets valued at €1.22 billion, securing €761 million in investment to reduce net debt by nearly €700 million, exceeding its €1.5 billion divestment target from mid-2022 to end-2025, while retaining control and 90% of future value creation; it also strengthened liquidity in 2025 through new factoring programs totaling over €225 million for clinics and extended operations, alongside achieving positive free cash flow of €26 million in H1 2025 and Q3 revenue growth of 5.6% driven by occupancy gains. In June 2025, Emeis formalized its status as a mission-driven company, embedding commitments to societal inclusion, care profession attractiveness, local cohesion, and sustainable innovation; it completed asset sales including Irish real estate in June 2024 as part of ongoing restructuring under its Refoundation Plan launched in 2022. The company reported €5.636 billion in 2024 revenue, with 93% beneficiary satisfaction worldwide, positioning it to address demographic challenges in aging populations and mental health.